S. Yalcin Et Al. , "Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.," Gastrointestinal Cancers Symposium , vol.36, San-Francisco, Costa Rica, 2018
Yalcin, S. Et Al. 2018. Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.. Gastrointestinal Cancers Symposium , (San-Francisco, Costa Rica).
Yalcin, S., Dane, F., Oksuzoglu, B., Yildirim, N., Isikdogan, A., Ozkan, M., ... Demirag, G.(2018). Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study. . Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica
Yalcin, Suayib Et Al. "Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.," Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica, 2018
Yalcin, Suayib Et Al. "Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.." Gastrointestinal Cancers Symposium , San-Francisco, Costa Rica, 2018
Yalcin, S. Et Al. (2018) . "Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.." Gastrointestinal Cancers Symposium , San-Francisco, Costa Rica.
@conferencepaper{conferencepaper, author={Suayib Yalcin Et Al. }, title={Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.}, congress name={Gastrointestinal Cancers Symposium}, city={San-Francisco}, country={Costa Rica}, year={2018}}